ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 154 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $751,942 | +27.2% | 67,318 | +143.7% | 0.10% | +17.3% |
| Q2 2023 | $591,047 | +7.9% | 27,619 | +138.2% | 0.08% | +68.8% |
| Q2 2022 | $548,000 | -25.5% | 11,597 | -10.5% | 0.05% | -9.4% |
| Q3 2021 | $736,000 | -27.0% | 12,954 | -43.4% | 0.05% | -20.9% |
| Q2 2021 | $1,008,000 | +3.4% | 22,900 | +15.9% | 0.07% | -4.3% |
| Q1 2021 | $975,000 | -3.1% | 19,763 | -17.3% | 0.07% | +2.9% |
| Q4 2020 | $1,006,000 | +13.3% | 23,900 | +23.2% | 0.07% | +15.3% |
| Q3 2020 | $888,000 | -38.9% | 19,400 | -33.0% | 0.06% | -40.4% |
| Q2 2020 | $1,453,000 | +198.4% | 28,942 | +114.6% | 0.10% | +800.0% |
| Q3 2015 | $487,000 | +73.3% | 13,485 | +116.0% | 0.01% | +57.1% |
| Q2 2015 | $281,000 | -34.8% | 6,242 | -55.6% | 0.01% | -36.4% |
| Q1 2015 | $431,000 | – | 14,068 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |